Skip to main content

Table 1 Demographic and available clinical information

From: Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?

Case number TTP (months) OS (months) ETBR expression Age (years) Gender Extent of resection
Radical Partial
K7686-2004 4 5 3+ 73 M No Yes
K9802-2004 5 5 1+ 68 M Yes No
K4448-2004 1 14 1+ 66 M No Yes
K12700-2004 1 5 1+ 64 F Yes No
K10452-2004 7 10 1+ 59 F Yes No
K5126-2004 3 7 1+ 57 M Yes No
K11136-2004 12 20 1+ 56 M Yes No
K17437-2004 16 17 2+ 56 M Yes No
K4840-2004 7 20 1+ 55 M Yes No
K16204-2004 10 11 1+ 54 M Yes No
K9236-2004 12 15 1+ 49 F Yes No
K16178-2004 12 13 1+ 45 M Yes No
K3839-2004 12 14 3+ 28 M Yes No
K16102-2004 48 48 1+ 57 F Yes No
K17407-2004 48 48 1+ 26 F Yes No
K10315-2004 52 52 1+ 29 M Yes No
K3174-2004 15 19 3+ 79 F Yes No
K16595/04 17 36 1+ 53 F Yes No
K1716-2005 7 82 1+ 43 M Yes No
K3349-2005 3 3 3+ 79 F No Yes
K8622-2005 9 12 3+ 59 F Yes No
K9731-2005 4 7 3+ 52 F Yes No
K15725-2005 2 4 2+ 54 M Yes No
K16886-2005 4.5 14.5 2+ 38 F No Yes
K17972-2005 8.5 18 1+ 63 F Yes No
  1. TTP time to tumor progression, OS overall survival; Staining was graded as low (1+) or high (2+ and 3+)